A polymorphic microsatellite that mediates induction of PIG3 by p53

Nature Genetics

Volumn 30, Issue 3, 2002, Pages 315-320

  Contente, Ana ^a   Dittmer, Alexandra ^a   Koch, Manuela C ^a   Roth, Judith ^a   Dobbelstein, Matthias ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53; TRANSCRIPTION FACTOR;

ALLELISM; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; GENE ACTIVATION; GENE INDUCTION; GENETIC POLYMORPHISM; GERMANY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEINS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036510121     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng836     Document Type: Article

References (22)

1. A model for p53-induced apoptosis
2. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain
3. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression
4. Sequence-specific DNA binding by p53: Identification of target sites and lack of binding to p53 - MDM2 complexes
5. A transcriptionally active DNA-binding site for human p53 protein complexes
6. p53, the cellular gatekeeper for growth and division
7. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity
8. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations
9. The polyproline region of p53 is required to activate apoptosis but not growth arrest
10. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest
11. p53 induces TAP1 and enhances the transport of MHC class I peptides
12. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
13. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E 1A protein
14. Kinetics of p53 binding to promoter sites in vivo
15. Evolution of simple repeats in DNA and their relation to human disease
16. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein
17. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins
18. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53
19. Nucleocytoplasmic shuttling of the hdm 2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodefidency virus rev protein
20. A simplified system for generating recombinant adenoviruses
21. Efficient replication of adenovirus despite the overexpression of active and non-degradable p53
22. Regulation of the specific DNA binding function of p53